 Jason Mansoori
Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 1 | 2024 | 827 | 0.610 |
Why?
| | Shock | 1 | 2020 | 98 | 0.600 |
Why?
| | Fluid Therapy | 1 | 2020 | 147 | 0.590 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2017 | 22 | 0.550 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 23 | 0.550 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2017 | 135 | 0.520 |
Why?
| | Early Detection of Cancer | 1 | 2017 | 447 | 0.380 |
Why?
| | Respiration, Artificial | 3 | 2021 | 645 | 0.360 |
Why?
| | Risk Assessment | 1 | 2017 | 3457 | 0.280 |
Why?
| | Critical Care | 2 | 2024 | 601 | 0.260 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2526 | 0.210 |
Why?
| | Health Policy | 1 | 2024 | 388 | 0.180 |
Why?
| | Patient Positioning | 1 | 2021 | 67 | 0.170 |
Why?
| | Risk Adjustment | 1 | 2020 | 78 | 0.160 |
Why?
| | Area Under Curve | 1 | 2020 | 314 | 0.150 |
Why?
| | Length of Stay | 1 | 2024 | 1215 | 0.150 |
Why?
| | ROC Curve | 1 | 2020 | 554 | 0.140 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2009 | 82 | 0.140 |
Why?
| | Resuscitation | 1 | 2020 | 251 | 0.140 |
Why?
| | Tomography, Emission-Computed | 1 | 2017 | 66 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 318 | 0.140 |
Why?
| | Dyspnea | 1 | 2019 | 254 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2020 | 1316 | 0.130 |
Why?
| | Radiopharmaceuticals | 1 | 2017 | 178 | 0.130 |
Why?
| | Pandemics | 1 | 2024 | 1639 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2017 | 786 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1587 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2020 | 7635 | 0.090 |
Why?
| | Middle Aged | 4 | 2021 | 33479 | 0.080 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2009 | 16 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2691 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 437 | 0.060 |
Why?
| | Aged | 3 | 2021 | 23961 | 0.060 |
Why?
| | Humans | 5 | 2024 | 137585 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2021 | 15657 | 0.060 |
Why?
| | Myosin Heavy Chains | 1 | 2006 | 192 | 0.060 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2006 | 142 | 0.060 |
Why?
| | Female | 5 | 2021 | 73304 | 0.060 |
Why?
| | Ventricular Remodeling | 1 | 2006 | 266 | 0.050 |
Why?
| | Prone Position | 1 | 2021 | 30 | 0.040 |
Why?
| | Male | 5 | 2021 | 67762 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 512 | 0.040 |
Why?
| | Glycogen Synthase Kinase 3 beta | 2 | 2009 | 72 | 0.030 |
Why?
| | Signal Transduction | 1 | 2009 | 5079 | 0.030 |
Why?
| | Phosphorylation | 2 | 2009 | 1759 | 0.030 |
Why?
| | Heart Ventricles | 2 | 2009 | 788 | 0.020 |
Why?
| | Troponin T | 1 | 2009 | 65 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 133 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 298 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 477 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 307 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2009 | 810 | 0.020 |
Why?
| | Adult | 2 | 2021 | 37929 | 0.020 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2006 | 38 | 0.020 |
Why?
| | Atrial Natriuretic Factor | 1 | 2006 | 57 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2006 | 137 | 0.020 |
Why?
| | Mutation | 2 | 2009 | 3958 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1325 | 0.020 |
Why?
| | Dietary Proteins | 1 | 2006 | 135 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2006 | 218 | 0.010 |
Why?
| | Myocardial Contraction | 1 | 2006 | 341 | 0.010 |
Why?
| | Body Weight | 1 | 2009 | 985 | 0.010 |
Why?
| | Actins | 1 | 2006 | 416 | 0.010 |
Why?
| | Kaplan-Meier Estimate | 1 | 2006 | 889 | 0.010 |
Why?
| | Fibrosis | 1 | 2006 | 552 | 0.010 |
Why?
| | Myocardium | 1 | 2009 | 1002 | 0.010 |
Why?
| | United States | 1 | 2021 | 14841 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2167 | 0.010 |
Why?
| | Sex Factors | 1 | 2006 | 2071 | 0.010 |
Why?
| | Mice | 2 | 2009 | 17787 | 0.010 |
Why?
| | Phenotype | 1 | 2009 | 3196 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2607 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 2833 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2006 | 4295 | 0.010 |
Why?
| | Time Factors | 1 | 2006 | 6828 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2006 | 5757 | 0.010 |
Why?
| | Animals | 2 | 2009 | 36940 | 0.010 |
Why?
|
|
Mansoori's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|